{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:11:18Z","timestamp":1791886278889,"version":"4.3.4"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,8,21]]},"DOI":"10.1001\/jama.2018.10400","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T16:34:55Z","timestamp":1535042095000},"page":"687","source":"Crossref","is-referenced-by-count":267,"title":["Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing"],"prefix":"10.1001","volume":"320","author":[{"given":"Joy","family":"Melnikow","sequence":"first","affiliation":[{"name":"University of California, Davis, Center for Healthcare Policy and Research, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian T.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany U.","family":"Burda","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn A.","family":"Senger","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauna","family":"Durbin","sequence":"additional","affiliation":[{"name":"University of California, Davis, Center for Healthcare Policy and Research, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan S.","family":"Weyrich","sequence":"additional","affiliation":[{"name":"University of California, Davis, Center for Healthcare Policy and Research, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9590","key":"jus180018r1","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer.","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"25","key":"jus180018r2","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1038\/sj.onc.1206629","article-title":"A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.","volume":"22","author":"Ziegert","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"jus180018r3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer.","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"jus180018r5","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases.","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"jus180018r6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States.","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"jus180018r7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.6004\/jnccn.2014.0035","article-title":"Cervical cancer screening.","volume":"12","author":"Partridge","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"jus180018r9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"jus180018r10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/LGT.0b013e3181dc115b","article-title":"Self-collection for vaginal human papillomavirus testing: systematic review of studies asking women their perceptions.","volume":"14","author":"Huynh","year":"2010","journal-title":"J Low Genit Tract Dis"},{"issue":"9","key":"jus180018r12","doi-asserted-by":"publisher","first-page":"e1002388","DOI":"10.1371\/journal.pmed.1002388","article-title":"Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial.","volume":"14","author":"Canfell","year":"2017","journal-title":"PLoS Med"},{"issue":"1","key":"jus180018r13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial.","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"jus180018r14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"jus180018r16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"issue":"3","key":"jus180018r17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process.","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"jus180018r19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12885-015-1959-5","article-title":"Comparison of the Roche cobas\u00ae 4800 and Digene Hybrid Capture\u00ae 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.","volume":"15","author":"Cook","year":"2015","journal-title":"BMC Cancer"},{"issue":"7","key":"jus180018r20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"jus180018r21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.v140.2","article-title":"HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.","volume":"140","author":"Ogilvie","year":"2017","journal-title":"Int J Cancer"},{"key":"jus180018r22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2407-10-111","article-title":"A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL trial).","volume":"10","author":"Ogilvie","year":"2010","journal-title":"BMC Cancer"},{"key":"jus180018r23","doi-asserted-by":"publisher","first-page":"e7789","DOI":"10.1136\/bmj.e7789","article-title":"Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.","volume":"345","author":"Leinonen","year":"2012","journal-title":"BMJ"},{"issue":"10","key":"jus180018r24","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/1471-0528.14575","article-title":"A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.","volume":"24","author":"Zorzi","year":"2017","journal-title":"BJOG"},{"issue":"7","key":"jus180018r25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"issue":"11","key":"jus180018r26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"jus180018r27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(ISSN)1097-0215","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"jus180018r28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"jus180018r29","doi-asserted-by":"publisher","first-page":"i4924","DOI":"10.1136\/bmj.i4924","article-title":"Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.","volume":"355","author":"Dijkstra","year":"2016","journal-title":"BMJ"},{"issue":"16","key":"jus180018r30","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"jus180018r31","doi-asserted-by":"publisher","first-page":"g130","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.","volume":"348","author":"Elfstr\u00f6m","year":"2014","journal-title":"BMJ"},{"issue":"4","key":"jus180018r32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/ijg.2008.18.issue-4","article-title":"The psychosocial impact of human papillomavirus testing in primary cervical screening\u2014a study within a randomized trial.","volume":"18","author":"Kitchener","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"51","key":"jus180018r33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta13510","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"issue":"7","key":"jus180018r34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"issue":"23","key":"jus180018r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.","volume":"18","author":"Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"issue":"3","key":"jus180018r36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/AOG.0b013e318209da59","article-title":"Variable risk of cervical precancer and cancer after a human papillomavirus-positive test.","volume":"117","author":"Castle","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"7","key":"jus180018r37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"jus180018r38","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1097\/LGT.0b013e318285437b","article-title":"Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"5","key":"jus180018r39","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"jus180018r40","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"jus180018r41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ijc.v136.7","article-title":"Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.","volume":"136","author":"Gage","year":"2015","journal-title":"Int J Cancer"},{"key":"jus180018r42","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/1471-2407-14-574","article-title":"Protecting the underscreened women in developed countries: the value of HPV test.","volume":"14","author":"Ib\u00e1\u00f1ez","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"jus180018r43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ygyno.2012.10.017","article-title":"Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany.","volume":"128","author":"Petry","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"6","key":"jus180018r44","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.v135.6","article-title":"Early detection of CIN3 and cervical cancer during long-term follow-up using HPV\/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.","volume":"135","author":"Luyten","year":"2014","journal-title":"Int J Cancer"},{"issue":"12","key":"jus180018r45","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/bjo.2004.111.issue-12","article-title":"Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.","volume":"111","author":"McCaffery","year":"2004","journal-title":"BJOG"},{"issue":"9916","key":"jus180018r47","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"jus180018r48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study.","volume":"168","author":"Castle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"jus180018r49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/LGT.0000000000000343","article-title":"Risks of CIN 2+, CIN 3+, and cancer by cytology and human papillomavirus status: the foundation of risk-based cervical screening guidelines.","volume":"21","author":"Demarco","year":"2017","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"jus180018r50","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1097\/AOG.0000000000001721","article-title":"Similar risk patterns after cervical screening in two large U.S. populations: implications for clinical guidelines.","volume":"128","author":"Gage","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"12","key":"jus180018r51","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/bjc.2016.368","article-title":"Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.","volume":"115","author":"Coldman","year":"2016","journal-title":"Br J Cancer"},{"issue":"6","key":"jus180018r52","first-page":"CD001318","article-title":"Surgery for cervical intraepithelial neoplasia.","author":"Martin-Hirsch","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"jus180018r53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0020-7292(99)00162-9","article-title":"Treatment outcomes for squamous intraepithelial lesions.","volume":"68","author":"Nuovo","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"jus180018r54","first-page":"CD008478","article-title":"Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia.","author":"Kyrgiou","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"jus180018r55","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/AOG.0000000000000174","article-title":"Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis.","volume":"123","author":"Conner","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"10","key":"jus180018r56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7326\/0003-4819-155-10-201111150-00377","article-title":"Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.","volume":"155","author":"Vesco","year":"2011","journal-title":"Ann Intern Med"},{"issue":"44","key":"jus180018r57","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening\u2014United States, 2007-2012.","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"jus180018r58","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.27790","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.","volume":"132","author":"Snijders","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"jus180018r59","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis.","volume":"104","author":"Racey","year":"2013","journal-title":"Can J Public Health"},{"key":"jus180018r60","doi-asserted-by":"publisher","first-page":"107497","DOI":"10.1155\/2011\/107497","article-title":"Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I\u2014all cancers and lung cancer and part II\u2014colorectal, prostate, breast, and cervical cancers.","volume":"2011","author":"Singh","year":"2011","journal-title":"J Cancer Epidemiol"},{"issue":"13","key":"jus180018r61","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer"},{"key":"jus180018r11","volume-title":"Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force","author":"Vesco","year":"2011"},{"key":"jus180018r15","volume-title":"Human Development Report","author":"United Nation Development Programme","year":"2016"},{"key":"jus180018r46","volume-title":"US Preventive Services Task Force Procedure Manual","author":"US Preventive Services Task Force","year":"2015"},{"key":"jus180018r4","unstructured":"American Cancer Society. Cancer Facts & Figures 2016. American Cancer Society website. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2016.html. Published 2016. Accessed June 27, 2017."},{"key":"jus180018r8","unstructured":"Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: cervical cancer. SEER website. https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Published 2017. Accessed July 3, 2018."},{"key":"jus180018r18","unstructured":"WellsGA, SheaBJ, O\u2019ConnellDPJ, WelchV, LososM, TugwellP. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa Hospital Research Institute website. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. 2014. Accessed June 27, 2017."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jama\/fullarticle\/2697703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T21:13:49Z","timestamp":1571778829000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.10400"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,8,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.10400","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,21]]}}}